J. Schickli

发表

Conformational Changes in the Spike Glycoprotein of Murine Coronavirus Are Induced at 37°C either by Soluble Murine CEACAM1 Receptors or by pH 8

S. Weiss, D. Blau, B. Zelus, 2003, Journal of Virology.

Receptor specificity and receptor-induced conformational changes in mouse hepatitis virus spike glycoprotein.

S. Weiss, B. Zelus, J. Schickli, 2001, Advances in experimental medicine and biology.

The N-Terminal Region of the Murine Coronavirus Spike Glycoprotein Is Associated with the Extended Host Range of Viruses from Persistently Infected Murine Cells

L. Thackray, J. Schickli, K. Holmes, 2004, Journal of Virology.

Plasmid-only rescue of influenza A virus vaccine candidates.

A. García-Sastre, P. Palese, T. Nakaya, 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

Parainfluenza Virus Type 3 Expressing the Native or Soluble Fusion (F) Protein of Respiratory Syncytial Virus (RSV) Confers Protection from RSV Infection in African Green Monkeys

R. Spaete, J. Schickli, A. A. Haller, 2004, Journal of Virology.

An S101P Substitution in the Putative Cleavage Motif of the Human Metapneumovirus Fusion Protein Is a Major Determinant for Trypsin-Independent Growth in Vero Cells and Does Not Alter Tissue Tropism in Hamsters

R. Spaete, J. Schickli, J. Kaur, 2005, Journal of Virology.

A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys

A. Osterhaus, R. Fouchier, Hui Liu, 2004, Vaccine.

Recovery of Human Metapneumovirus Genetic Lineages A and B from Cloned cDNA

A. Osterhaus, Chin-fen Yang, R. Fouchier, 2004, Journal of Virology.

Identification of small-animal and primate models for evaluation of vaccine candidates for human metapneumovirus (hMPV) and implications for hMPV vaccine design.

A. Osterhaus, R. Fouchier, R. Spaete, 2004, The Journal of general virology.

Activation of Tumor Antigen-Specific Cytotoxic T Lymphocytes (CTLs) by Human Dendritic Cells Infected with an Attenuated Influenza A Virus Expressing a CTL Epitope Derived from the HER-2/neu Proto-Oncogene

A. García-Sastre, P. Palese, J. Schickli, 2003, Journal of Virology.

Recognition by HMPV-B1 Phosphoprotein Viral Interference of RIG-I Ligand Acid-Inducible Gene I (RIG-I) and TLR7 and Metapneumoviruses (HMPVs) by Retinoic Cell Type-Specific Recognition of Human

B. Monks, P. Kiener, J. Schickli, 2009 .

A novel influenza A virus mitochondrial protein that induces cell death

Jonathan W. Yewdell, Jack R. Bennink, J. Yewdell, 2001, Nature Medicine.

Challenges in developing a pediatric RSV vaccine

J. Schickli, F. Dubovsky, R. Tang, 2009, Human vaccines.

Deletion of human metapneumovirus M2-2 increases mutation frequency and attenuates growth in hamsters

R. Spaete, J. Schickli, J. Kaur, 2008, Virology Journal.

The murine coronavirus mouse hepatitis virus strain A59 from persistently infected murine cells exhibits an extended host range

B. Zelus, J. Schickli, K. Holmes, 1997, Journal of virology.

Nonclinical phenotypic and genotypic analyses of a Phase 1 pediatric respiratory syncytial virus vaccine candidate MEDI-559 (rA2cp248/404/1030ΔSH) at permissive and non-permissive temperatures.

J. Schickli, J. Kaur, R. Tang, 2012, Virus research.

Using the sodium sulfate interference for lead to test the fork platform design

J. Schickli, W. Slavin, G. Carnrick, 1990 .

Cell Type-Specific Recognition of Human Metapneumoviruses (HMPVs) by Retinoic Acid-Inducible Gene I (RIG-I) and TLR7 and Viral Interference of RIG-I Ligand Recognition by HMPV-B1 Phosphoprotein

B. Monks, P. Kiener, J. Schickli, 2009, The Journal of Immunology.

Evaluation of attenuation, immunogenicity and efficacy of a bovine parainfluenza virus type 3 (PIV-3) vaccine and a recombinant chimeric bovine/human PIV-3 vaccine vector in rhesus monkeys.

J. Schickli, A. A. Haller, K. Coelingh, 2003, The Journal of general virology.

Effects of Human Metapneumovirus and Respiratory Syncytial Virus Antigen Insertion in Two 3′ Proximal Genome Positions of Bovine/Human Parainfluenza Virus Type 3 on Virus Replication and Immunogenicity

A. Osterhaus, R. Fouchier, R. Spaete, 2003, Journal of Virology.

Palivizumab epitope-displaying virus-like particles protect rodents from RSV challenge.

Michael P. McCarthy, J. Schickli, J. Kaur, 2015, The Journal of clinical investigation.

A single amino acid in the F2 subunit of respiratory syncytial virus fusion protein alters growth and fusogenicity

J. Schickli, R. Tang, Heather A. Lawlor, 2013, The Journal of general virology.

Implication of respiratory syncytial virus (RSV) F transgene sequence heterogeneity observed in Phase 1 evaluation of MEDI-534, a live attenuated parainfluenza type 3 vectored RSV vaccine.

Chin-fen Yang, J. Schickli, Elissa M. Malkin, 2013, Vaccine.

Selection in persistently infected murine cells of an MHV-A59 variant with extended host range.

B. Zelus, J. Schickli, K. Holmes, 1998, Advances in experimental medicine and biology.

Optimization of plasmid-only rescue of highly attenuated and temperature-sensitive respiratory syncytial virus (RSV) vaccine candidates for human trials.

R. Spaete, J. Schickli, J. Kaur, 2008, Journal of virological methods.